Creatinine Excretion as a Determinant of Accelerated Skeletal Muscle Loss with Critical Illness/Kritik Hastalikta Hizli Iskelet Kasi Kaybinin Belirleyicisi Olarak Kreatinin Ekskresyonu.
The amount of creatinine excreted over 24 h is a reflection of skeletal muscle (SM) mass (1, 2), and the expected excretion rate is at least 15 mg [kg.sup.-1] [day.sup.-1] in healthy women and the same or higher in healthy men. Lower rates may be found in elderly and very sick patients (3). Estimates (4, 5) and loss of muscle mass over time as determined by urinary creatinine excretion in the intensive care unit (ICU) are easy to obtain but have never been done. Therefore, the aim of the study was to compare reductions in muscle mass (as estimated from urinary creatinine excretion) in critically ill patients who were admitted to ICU at least twice.
A retrospective review of ICU patients who underwent 24-h urine collection for creatinine clearance measurement as part of routine ICU care that was subsequently repeated during a second separate ICU admission, an uncommon event, was conducted. In addition, the 24-h urine collections were performed during the steady state, as defined by stable creatinine levels during collections, to determine accurate creatinine clearances and with serum creatinine levels <2 mg d[L.sup.-1]. The 24-h creatinine excretion measurements are part of the procedure for determining renal function in ICU (6). Only three subjects were found with such data and were included.
Normal SM mass for women and men were defined as [greater than or equal to]6.76 and [greater than or equal to] 10.76 kg [m.sup.-2], respectively (7). Severe sarcopenia in women and men were defined as an SM mass of [less than or equal to]5.75 and [less than or equal to]8.50 kg [m.sup.-2], respectively (7). Primary sarcopenia is defined as the entity that occurs in some individuals with normal ageing. Secondary sarcopenia can occur without ageing and was seen in these three cases.
Skeletal muscle mass (in kilograms, kg) was calculated from urinary creatinine using the following formula: SM = 18.9 x Cr (grams) + 4.1 (5). Ideal body weight formulas were taken from the ARDSNET trial (8). Although a case series, the study design is one with patients as their own control (a comparison study).
The Institutional Review Board of Harlem Hospital Center waived approval for this retrospective case series of previously collected renal function/clinical data.
A 61-year-old, 72.3 kg female with hypertension, diabetes and recent stroke was admitted to ICU with new-onset intractable seizures despite treatment with multiple anticonvulsants. A 24-h urine collection revealed a urinary creatinine excretion of 1160 mg. She was eventually transferred to a seizure referral centre via ambulance to manage her seizures and was intubated on an intravenous infusion of midazolam. Four months later, she was transferred back from a nursing home, with a percutaneous endoscopic gastrostomy for feeding, to ICU with further intractable seizures and eventually required a tracheostomy due to poor seizure control. A repeat 24-h urine collection for creatinine excretion was performed three times because the measured creatinine excretion value was much lower than the previous one; the mean value was 322[+ or -]54 mg with a coefficient of variation of 16.7%. Her weight at second admission was 69.2 kg. Further history revealed that she had been bedridden since her last admission. Before her seizures, she lived at home and was ambulatory.
On the basis of creatinine excretion, her SM mass was 26 kg (9.2 kg [m.sup.-2]) on the first admission and 10.2 kg (3.6 kg [m.sup.-2]) on the second admission. Moderate sarcopenia in women is defined as an SM mass of 5.76-6.75 kg [m.sup.-2] (7). Therefore, she went from having a normal muscle mass to very low muscle mass, consistent with severe sarcopenia, within 4 months (Table 1).
A 56-year-old, 44-kg female with human immunodeficiency virus (HIV) infection was admitted for health care-associated pneumonia (HCAP) with a 24-h urinary creatinine excretion of 739 mg. She remained bedridden in the hospital, and computed tomography (CT) scan of her brain showed multiple brain lesions; furthermore, serum toxoplasmosis IgG negative and an altered mental status were detected. Neurosurgical evaluation indicated a weakened state; thus, no biopsy was performed. Seven weeks later, a repeat 24-h urine collection, following a tracheostomy, revealed a urine creatinine excretion of 263 mg. Her calculated SM mass went from 7.8 kg [m.sup.-2] to 3.9 kg [m.sup.-2] within 54 days, indicating severe sarcopenia (Table 1). She was bedridden during this 54-day period.
A tall 62-year-old, 51 kg male was admitted to ICU and intubated for respiratory failure secondary to HCAP. He had a previous history of hepatitis C, HIV infection and head and neck cancer. A 24-h urine collection was obtained with a urinary creatinine excretion of 1055 mg. He was successfully treated and extubated and transferred to the medical unit. Eighty-five days later, he was re-admitted for a recurrent pneumonia and was intubated. The pneumonia in his right lung progressed to adult respiratory distress syndrome. He was oedematous with a marked increase in weight to 76.8 kg from 51 kg. A repeat 24-h urine collection revealed a creatinine excretion of 452 mg (average of two collections) (Table 1).
This patient started off as a sarcopenic and gradually lost even more muscle mass, albeit he weighed more with less creatinine excretion, suggesting a gradual increase in water weight and not SM mass.
This case series, comprising three ICU patients who became bedridden after their first ICU admission, is the first to demonstrate the rapidity with which an individual can lose muscle mass, as demonstrated by a >50% reduction in creatinine excretion over an average span of only 75 days (Table 2). It should be noted that the accuracy of urine collections for 24-h creatinine excretion in ICU is much better than that of ambulatory creatinine excretions due to both the controlled situation and the fact that critically ill patients have Foley catheters in place (3).
All patients met the definition of sarcopenia by the second admission, including the one with HIV infection who was sarcopenic on both ICU admissions. We defined sarcopenia as reduced SM mass, although the full definition includes reduced SM mass along with reduced strength/mobility (7). The reduced strength/mobility was assumed in all three patients as they could not be tested because of being bedridden. Sarcopenia with ageing is well known to increase mortality in community dwellers compared with similarly aged groups without sarcopenia (9, 10), and the estimated prevalence of sarcopenia in ambulatory older adults is 4.6% for men and 7.9% for women with a mean age of 67 years (11). Undoubtedly, subjects with disabilities and in nursing homes have a higher prevalence of sarcopenia. All three of our patients died with severe sarcopenia within 1 month of their second ICU admission. All three deaths were related to ongoing septic complications (Table 2). However, the weakened state secondary to reduced muscle mass undoubtedly increased the likelihood of death among these patients.
Normally, SM mass starts to decrease among healthy women and men at about 45 years of age (12, 13), with increased functional impairment and disability occurring later and primary sarcopenia occurring in some patients with ageing (13). However, as demonstrated here, sarcopenia can occur within 2 (54 days) to 4 (135 days) months in the critically ill. The extremely rapid loss of muscle mass may have been secondary to immobility; lack of muscle loading that goes with immobility, resulting in muscle loss due to lack of protein synthesis and normal protein degradation; ongoing sepsis with necrotising myopathy; intermittent periods of malnutrition (often for procedures); and insulin resistance/glucose intolerance partly related to less glucose uptake by muscles secondary to a reduced muscle mass (7, 14-18) because 75% of glucose uptake is by SM (19). Once patient is debilitated due to the ICU course and newly acquired secondary sarcopenia, nosocomial infections are more likely to occur (20), causing a vicious cycle.
A previous ICU study in 149 elderly (age [greater than or equal to]65 years) surgical trauma patients classified patients on the basis of presence or absence of sarcopenia using a muscle index obtained using a CT scan (18). The overall mortality was 27% in the study population, with twice the number of sarcopenic patients dying compared with non-sarcopenic patients (p<0.025). In addition, multivariate linear regression revealed that sarcopenia was associated with decreased ventilator-free (p<0.01) and ICU-free (p<0.01) days. This study suggests that greater muscularity among the elderly is associated with less mortality and morbidity after trauma (18).
A limitation of our study is the estimation of SM mass from urinary creatinine excretion using equations for prediction that were devised in a study on 12 healthy adult men who were on a meat-free diet for several days before their urine samples were obtained (5). Their creatinine excretion data were compared with multiscan CT, which entailed some radiation exposure, and equations for SM mass were developed from creatinine excretion (5). Therefore, exact values may not be as accurate in adult women. In addition, critically ill patients in the medical ICU are not the same as healthy adults without medical problems. The major requirement for urine collection was stable serum creatinine levels throughout the 24-h ICU urine collection to predict creatinine clearances, as done previously (6).
Therefore, the creatinine excretion results should be correct and be fairly accurate in detecting changes in creatinine excretion over time. Furthermore, reductions in creatinine excretion do reflect reductions in SM mass, albeit the exact translation of urinary creatinine excretion to actual SM loss will be qualitatively correct and can serve as a quantitative approximation of the true value (5).
Another limitation is that all critical care patients in our ICU are provided enteral nutrition within 36 h, if not before, with a goal of providing at least 25 kcal [kg.sup.-1] [day.sup.-1] of ideal body weight. However, we do not have the precise quantitation of the nutritional support provided compared with a formal study (5).
An advantage of using urinary creatinine excretion as a biomarker for estimating SM mass in ICU is the rapid and inexpensive ease of collection with indwelling Foley catheters in place (2, 3). As long as the serum creatinine levels are not changing, the creatinine excretion should be accurate, and the creatinine clearance obtained has been shown to correlate fairly well with Cockcroft and Gault's estimation using lean body weight (6). Strength of this study is comparison, patients as their own control, which adjusts for gender, age and genetics by default.
Patient 3 illustrates why body mass index (BMI) is not a useful marker for body composition in critically ill patients (Table 1). The patients initial mass of 51 kg revealed a BMI of 15.2 kg [m.sup.-2]. On re-admission, the patient's mass increased by >25 kg with an increase in BMI to 22.9 kg [m.sup.-2]. However, during this change, his creatinine excretion dropped by 57% and estimated SM mass dropped by 42%, clearly revealing an increase in water, not SM, mass. Patients 1 and 2 illustrate this point as well. Both had a similar BMI on both visits, yet urinary creatinine dropped by >50% (Table 1). Therefore, body composition is changing as indicated by a decrease in SM mass, yet BMI is essentially unchanged.
Critically ill patients can develop severe sarcopenia within 4 months as estimated from 24-h urinary creatinine excretion data. A common thread is that all the three patients became bed bound after their first medical ICU admission and all developed sepsis during the second ICU admission. Severe sarcopenia predisposes to subsequent infections (19) and may result in a very high mortality due to the inability to control the downward spiral of disease. Screening for the presence of sarcopenia in ICU using 24-h urinary creatinine excretion measurements (6) or possibly ultrasound (21), in case of unstable renal function, may be helpful as a diagnostic and prognostic marker. Larger studies will be needed to determine morbidity/mortality in ICU patients who are detected as having severely reduced SM mass. It is possible that most patients who develop severe sarcopenia during their ICU course will not survive.
Prevention of SM loss in ICUs should include early mobilisation when possible (22) to stimulate muscle protein synthesis (15, 16), early nutritional support including adequate protein intake in an attempt to minimise SM loss, and controlling infection and the precipitating process that resulted in admission to ICU.
Ethics Committee Approval: Ethics committee approval was received for this study from the ethics committee of Harlem Hospital Center (BRANY IRB file #15-15-298-273 (HHC).
Informed Consent: Written informed consent was not needed for this retrospective chart review as determined by the Harlem Hospital Center IRB.
Peer-review: Externally peer-reviewed.
Author Contributions: Concept--J.K., G.R.P.; Design--G.R.P.; Supervision--J.K., G.R.P.; Data Collection and/or Processing--J.K., K.B., EH., G.K., G.R.P.; Analysis and/or Interpretation--J.K., K.B., F.H., G.K., G.R.P.; Literature Search--J.K., G.R.P; Writing Manuscript--G.RP, J.K.; Critical Review--J.B., K.B., F.H., G.K., G.R.P.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study has received no financial support.
Etik Komite Onayi: Bu calisma icin etik komite onayi Harlem Hastane Merkezi'nden (BRANY IRB file #15-15-298-273 (HHC) alinmistir.
Hasta Onami: Harlem Hastanesi Merkezi IRB tarafindan belirlenen bu retrospektif grafik incelemesi icin yazili bilgilendirilmis onamaya gerek yoktur.
Hakem Degerlendirmesi: Dis bagimsiz.
Yazar Katkilari: Fikir--J.K., G.R.P.; Tasarim--G.R.P.; Denetleme--J.K., G.R.P.; Veri Toplanmasi ve/veya Islemesi--J.K., K.B., F.H., G.K., G.R.P.; Analiz ve/veya Yorum--J.K., K.B., F.H., G.K., G.R.P; Literatur Taramasi--J.K., G.R.P.; Yaziyi Yazan--G.R.P, J.K.; Elestirel Inceleme--J.B., K.B., F.H., G.K., G.RP
Cikar Catismasi: Yazarlar cikar catismasi bildirmemislerdir.
Finansal Destek: Yazarlar bu calisma icin finansal destek almadiklarini beyan etmislerdir.
(1.) Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr 1976; 29: 1359-66. [CrossRef]
(2.) Kalantari K, Bolton WK. A good reason to measure 24-hour urine creatinine excretion, but not to assess kidney function. Clin J Am Soc Nephrol 2013; 8: 1847-9. [CrossRef]
(3.) Pesola GR, Akhavan I, Carlon GC Urinary creatinine excretion in the ICU: low excretion does not mean inadequate collection. Am J Crit Care 1993; 2: 462-6.
(4.) Heymsfield SB, Arteaga C, McManus C, Smith J, Moffit S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr 1983; 37: 478-94. [CrossRef]
(5.) Wang Z, Gallagher D, Nelson ME, Matthews DE, Heymsfield SB. Total-body skeletal muscle mass: evaluation of 24-h urinary creatinine excretion by computerized axial tomography. Am J Clin Nutr 1996; 63: 863-9. [CrossRef]
(6.) Pesola GR, Akhavan I, Madu A, Shah NK, Carlon GC. Prediction equation estimates of creatinine clearance in the intensive care unit. Intensive Care Med 1993; 19: 39-43. [CrossRef]
(7.) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boire Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010; 39: 412-23. [CrossRef]
(8.) ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-8. [CrossRef]
(9.) Bigaard J, Fredericksen K, Tjonneland A, Thomsen BL, Overvad K, Heitmann Bl, et al. Body fat and fat-free mass and all-cause mortality. Obesity Res 2004; 12: 1042-9. [CrossRef]
(10.) Bunout D, de la Maza MP, Barrera G, Leiva L, Hirsch S. Association between sarcopenia and mortality in healthy older people. Australian J Ageing 2011; 30: 89-92. [CrossRef]
(11.) Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, et al. Prevalence of sarcopenia in community dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 2013; 42: 378-84. [CrossRef]
(12.) Janssen I, Heymsfield SB, Wang Z, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol 2000; 89: 81-8. [CrossRef]
(13.) Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability in older men and women. Am J Epidemiol 2004; 159:413-21. [CrossRef]
(14.) Chambers MA, Moylan JS, Reid MB. Physical inactivity and muscle weakness in the critically ill. Crit Care Med 2009; 37(Suppl 10):S337-46.
(15.) Breen L, Stokes KA, Churchward-Venne TA, Moore DR Baker SK, Smith K, et al. Two weeks of reduced activity decreases leg lean mass and induces "anabolic resistance" of myofibrillar protein synthesis in healthy elderly. J Clin Endocrinol Metab 2013; 98: 2604-12. [CrossRef]
(16.) Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. Acute skeletal muscle wasting in critical illness. JAMA 2013; 210: 1591-600. [CrossRef]
(17.) Batt J, Dos Santos CC, Herridge MS. Muscle injury during critical illness. JAMA 2013; 210: 1569-70. [CrossRef]
(18.) Moisey LL, Mourtzakis M, Cotton BA, Premji T, Heyland DK, Wade CE, et al. Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Critical Care 2013; 17: R206.
(19.) DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30: 1000-7. [CrossRef]
(20.) Cosqueric G, Sebag A, Ducolombier C, Thomas C, Piette F, Weill-Engerer S. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 2006; 96: 895-901. [CrossRef]
(21.) Gruther W, Benesch T, Zorn C, Paternostro-Sluga T, Quittan M, Fialko-Moser V, et al. Muscle wasting in intensive care patients: ultrasound observation of the M. Quadriceps Femoris muscle layer. J Rehab Med 2008; 40: 185-9. [CrossRef]
(22.) Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomized controlled trial. Lancet 2009; 373: 1874-82. [CrossRef]
Jehanzeb Khan (1), Khushbir Bath (1), Fareeha Hafeez (1), Gayoung Kim (2), Gene R. Pesola (1)
(1) Department of Medicine, Section of Critical Care/Pulmonary Medicine, Harlem Hospital/Columbia University, New York, USA
(2) Department of Nursing, Harlem Hospital/Columbia University, New York, USA
Cite this article as: Khan J, Bath K, Hafeez F, Kim G, Pesola GR. Creatinine Excretion as a Determinant of Accelerated Skeletal Muscle Loss with Critical Illness. Turk J Anaesthesiol Reanim 2018; 46(4): 311-5.
Presented, inpart, at the American Thoracic Society meeting in Denver, Colorado, May 15-20, 2015. In memory of At Teirstein, the previous section chief of pulmonary disease at Mt. Sinai Hospital, New York City for previous generous support.
Kismen, Colorado Denver'da, 15-20 Mayis 2015'te American Toraks Dernegi toplantmnda sunulmustur. Sagladgi comert destekleri icin, New York'ta bulunan Mt. Sinai Hastanesi akciger hastahklari eski bolum sefi Al Teirsteinin amsina.
Received / Gelis Tarihi: 13.01.2017
Accepted / Kabul Tarihi: 09.02.2018
Available Online Date / Cevrimici Yayin Tarihi: 25.06.2018
Table 1. Summary of creatinine excretion and SM mass calculations 24-hr urine Creatinine Attributes Weight kg BMI creatinine (mg) mg [kg.sup.-1] [day.sup.-1] Case 1 Visit 1 72.3 25.6 1160 16.0 Visit 2 69.2 24.5 322 4.7 I.D. Wt. 59.6 21.1 19.5,5.4 Case 2 Visit 1 44.0 19.0 739 16.8 Visit 2 75.4 32.6 263 3.5 I.D. Wt. 45.5 19.7 16.2,5.8 Case 3 Visit 1 51.0 15.2 1056 20.7 Visit 2 76.8 22.9 452 5.9 I.D. Wt. 77.7 23.2 13.6,5.8 Calculated SM Attributes mass (kg) SM kg [m.sup.-1] Case 1 Visit 1 26.0 9.2 Visit 2 10.2 3.6 I.D. Wt. Case 2 Visit 1 18.1 7.8 Visit 2 9.1 3.9 I.D. Wt. Case 3 Visit 1 24.1 7.2 Visit 2 12.6 3.8 I.D. Wt. SM: skeletal muscle; SM mass formula in kg=18.9 X Cr (grams) + 4.1 (5); kg: kilograms; BMI:body mass index; 24-hr: 24 hour; I.D. Wt: ideal body weight. Normal SM mass (7) in women:>6.76 kg [m.sup.-2]; Normal SM mass (7) in men:>10.76 kg [m.sup.-2] Severe sarcopenia in women: SM <5.75 kg [m.sup.-2]; Severe sarcopenia in men: SM <8.50 kg [m.sup.-2] Table 2. Summary of creatinine excretion and mortality data Time between Percent drop Death after creatinine in creatinine second urine Attributes measurements excretion collection Case 1: 61-year-old female 135 days 72.2% 25 days Recurrent seizures Case 2: 56-year-old female 54 days 64.4% 3 days HIV infection Case 3: 62-year-old male 85 days 57.2% 12 days HIV infection Attributes Cause of death Case 1: 61-year-old female Septic shock with abdominal wall abscess Recurrent seizures Case 2: 56-year-old female Severe sepsis with fungaemia HIV infection Multiple brain masses on Decadron Case 3: 62-year-old male Septic shock with respiratory failure HIV infection from bilateral pneumonia HIV: human immunodeficiency virus
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Original Article / Ozgun Arastirma|
|Author:||Khan, Jehanzeb; Bath, Khushbir; Hafeez, Fareeha; Kim, Gayoung; Pesola, Gene R.|
|Publication:||Turkish Journal of Anaesthesiology and Reanimation|
|Date:||Aug 1, 2018|
|Previous Article:||Effect of Two Techniques of Parental Interaction on Children's Anxiety at Induction of General Anaesthesia-A Randomized Trial/Genel Anestezi...|
|Next Article:||Quick Evaluation of Cerebral Autoregulation Limits with Near Infrared Spectroscopic Techniques in the Intraoperative Period/Intraoperatif Donemde...|